These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 1359187)

  • 1. [Incubation vaccination ("post-exposure vaccination") with MMR vaccine during a mumps epidemic? The Pediatric Vaccine Counseling Unit].
    Wiersbitzky S; Bruns R; Beyer B
    Kinderarztl Prax; 1992 Oct; 60(7):207-8. PubMed ID: 1359187
    [No Abstract]   [Full Text] [Related]  

  • 2. [Encephalitis, meningitis serosa and parotitis after MMR preventive vaccination? The Pediatric Vaccination Counseling Unit].
    Wiersbitzky S; Bruns R; Peters A; Mentel R
    Kinderarztl Prax; 1992 Oct; 60(7):203-5. PubMed ID: 1359186
    [No Abstract]   [Full Text] [Related]  

  • 3. [Exanthema with high fever and cerebral seizure susceptibility after mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S; Bruns R; Mentel R
    Kinderarztl Prax; 1993 Aug; 61(6):227-8. PubMed ID: 8105135
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cerebral seizures and/or encephalitis after MMR, oral polio, HiB or DPT vaccination?].
    Wiersbitzky S; Bruns R; Schmidt U
    Kinderarztl Prax; 1993 Aug; 61(6):232-4. PubMed ID: 8105136
    [No Abstract]   [Full Text] [Related]  

  • 5. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W
    Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased risk of invasive bacterial infections after preventive mumps-measles-rubella vaccination?].
    Wiersbitzky S; Bruns R; Mentel R
    Kinderarztl Prax; 1993 Jun; 61(4-5):170-1. PubMed ID: 8361148
    [No Abstract]   [Full Text] [Related]  

  • 8. Meningoencephalitis associated with MMR vaccine.
    Maguire HC; Begg NT; Handford SG
    CDR (Lond Engl Rev); 1991 May; 1(6):R60-1. PubMed ID: 1688304
    [No Abstract]   [Full Text] [Related]  

  • 9. [Infant with febrile convulsions/incidental convulsions in the history: how does one proceed with diphtheria-pertussis-tetanus (DPT) and mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S; Bruns R; Burtzlaff C
    Kinderarztl Prax; 1993 Nov; 61(9):339-40. PubMed ID: 8114462
    [No Abstract]   [Full Text] [Related]  

  • 10. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 11. [Leukemoid reaction or leukosis after MMR preventive vaccination].
    Wiersbitzky S; Peters A; Reddemann H
    Kinderarztl Prax; 1993 May; 61(3):118-9. PubMed ID: 8326701
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
    Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva antibody testing and vaccination in a mumps outbreak.
    Ramsay ME; Brown DW; Eastcott HR; Begg NT
    CDR (Lond Engl Rev); 1991 Aug; 1(9):R96-8. PubMed ID: 1669793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute gastroenteritis and acute obstructive bronchitis after mumps-measles-rubella (MMR) preventive vaccination? The Pediatric Vaccination Counseling Service].
    Wiersbitzky S; Bruns R; Wiersbitzky H
    Kinderarztl Prax; 1992 Dec; 60(9-10):302-3. PubMed ID: 1289650
    [No Abstract]   [Full Text] [Related]  

  • 15. Measles/mumps/rubella vaccine: a new start.
    Midwife Health Visit Community Nurse; 1988 Sep; 24(9):347, 359. PubMed ID: 3205171
    [No Abstract]   [Full Text] [Related]  

  • 16. The measles-mumps-rubella vaccination program in Finland.
    Redd SC; Wharton M; Hadler SC; Orenstein WA
    N Engl J Med; 1995 Apr; 332(16):1102-3. PubMed ID: 7898540
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of MMR vaccine on mumps infection in England and Wales.
    Jones AG; White JM; Begg NT
    CDR (Lond Engl Rev); 1991 Aug; 1(9):R93-6. PubMed ID: 1669792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The measles-mumps-rubella vaccination program in Finland.
    Lerman SJ
    N Engl J Med; 1995 Apr; 332(16):1103. PubMed ID: 7898541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.